More exciting news from Thestra! Thestra and University of Turku have signed an agreement which will enable Thestra to use the high-end laboratory premises of Turku Bioscience Centre. This is an important step for Thestra in developing the revolutionary EPLINEx™ method for the diagnosis of aggressive head and neck cancer (HNSCC). Read more about this and Thestra at https://thestra.fi/ PS! Thestra´s CSO Jukka Westermarck recently presented the EPLINEX™ story at Navigating from Biomarker Discovery to Clinical Trial seminar organized by FIMM and HiLIFE Unit / University of Helsinki. In his presentation Jukka told and summarized the consistent basic science and research developments which have led to the establishment of Thestra Ltd.
Thestra
Biotechnology Research
Diagnostic tools to help clinicians assess cancer aggressiveness and choose effective therapies
About us
Our diagnostic solutions provide clinicians novel tools to estimate cancer aggressivity at the time of diagnosis and help them to select the most effective, and health economical therapies. CURRENT TARGET DISEASE Head and neck squamous cell carcinoma (HNSCC) Almost one million new cases annually 50% mortality rate No improvement in survival rate over the decades Lack of diagnostic method to identify deadly cancer cases BENEFITS FOR: CLINICIANS AND HOSPITALS Novel, accurate tool for diagnosis and prognosis Facilitated decision-making Cost savings PATIENTS Less side-effects Better quality of life through accurate diagnosis and personalised treatment THESTRA SOLUTION: Patented EPLINEx™ solution for identification of HNSCC cases that are life threatening. Artificial intelligence based HNSCC tissue analysis.
- Sivusto
-
https://www.thestra.fi
External link for Thestra
- Toimiala
- Biotechnology Research
- Yrityksen koko
- 2-10 employees
- Päätoimipaikka
- Turku
- Tyyppi
- Privately Held
- Perustettu
- 2023
Sijainnit
-
Ensisijainen
Get directions
Turku, FI
Työntekijät Thestra
Päivitykset
-
🌟 Exciting News from Thestra! 🌟 We’re thrilled to welcome PhD Mari Peltola to the Thestra family as our new Senior Scientist! Mari will play a pivotal role in driving the development of EPLINEx™, our flagship product in cancer diagnostics. With her extensive expertise and passion for innovation, she’s set to strengthen our mission of revolutionizing tools for early and precise cancer detection. A bit about Mari: Former Design Transfer Specialist at Wallac Oy Previous Research Director at Labmaster Oy PhD from the University of Turku, specializing in prostate cancer diagnostic tools Mari’s deep experience in both research and product development is perfectly aligned with our journey at Thestra. Welcome aboard, Mari! We can’t wait to see the incredible impact you’ll make. Check out more about what we do at https://thestra.fi/ #NewHire #TeamThestra #CancerDiagnostics #Innovation
Front page
https://thestra.fi